0.3615
-0.0379 (-9.49%)
-0.0379 (-9.49%)
Upgrade to Real-Time
Afterhours
| Volume | 559,717 |
|
|||||
| News | - | ||||||
| Day High | 0.3999 | Low High |
|||||
| Day Low | 0.3621 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0379 | -9.49% | 0.3615 | 18:42:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3901 | 0.3621 | 0.3999 | 0.3637 | 0.3994 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,290 | 559,717 | $ 0.3770786 | $ 211,057 | - | 0.25 - 2.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:50:23 | 99 | $ 0.3675 | USD |
Period:
Draw Mode:
Marker Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 30.22M | 83.60M | 58.84M | $ 1.24M | $ - | -0.56 | -0.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 400.00k | 21.70% |
Marker Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRKR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.51 | 0.56 | 0.3621 | 0.4671643 | 1,110,274 | -0.1485 | -29.12% |
| 1 Month | 0.35 | 0.66 | 0.2975 | 0.5207434 | 4,840,365 | 0.0115 | 3.29% |
| 3 Months | 0.35 | 0.66 | 0.25 | 0.5002962 | 1,883,071 | 0.0115 | 3.29% |
| 6 Months | 0.62 | 0.66 | 0.25 | 0.4829379 | 1,103,921 | -0.2585 | -41.69% |
| 1 Year | 1.90 | 2.05 | 0.25 | 0.7388328 | 840,349 | -1.54 | -80.97% |
| 3 Years | 5.07 | 6.54 | 0.25 | 1.94 | 855,247 | -4.71 | -92.87% |
| 5 Years | 10.01 | 10.25 | 0.25 | 2.43 | 758,922 | -9.65 | -96.39% |
Marker Therapeutics Description
| Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. |